Company intelligence / Profile preview

MBI Pharma

Ownership: Private
Development stage: Commercial

Overview

MBI Pharma currently sells more than 500 different unlicensed medicines as well as several registered medicines to major sick funds and government hospitals in Israel[2]

Modalities: Specialty pharmaceuticalsRare disease products
Industry: Drug Discovery Services

Partnerships

International pharmaceutical companies

Beyond the preview

Go deeper on MBI Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MBI Pharma.

Explore the full profile